Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Erfle

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Virological Methods|November 29, 2008
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selectionGiulia Di Lullo, Elisa Soprana, Maddalena Panigada, et al.
Experimental Cell Research|December 22, 2005
Analysis of the influence of subcellular localization of the HIV Rev protein on Rev-dependent gene expression by multi-fluorescence live-cell imagingHorst Wolff, Kamyar Hadian, Manja Ziegler, et al.
Vaccine|November 8, 2003
Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individualsAntonio Cosma, Rashmi Nagaraj, Silja Bühler, et al.
BMC Cell Biology|April 26, 2005
Identification of a novel Rev-interacting cellular proteinSusanne Kramer-Hämmerle, Francesca Ceccherini-Silberstein, Christian Bickel, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virusAntonio Cosma, Silja Bühler, Rashmi Nagaraj, et al.
Journal of Medical Virology|January 21, 2010
Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletesDieter Hoffmann, Bernd Wolfarth, Hubert G Hörterer, et al.
The Journal of General Virology|March 22, 2002
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaquesCharlotta Nilsson, Gerd Sutter, Lilian Walther-Jallow, et al.
AIDS Research and Human Retroviruses|July 3, 2007
Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAARTAntonio Cosma, Rashmi Nagaraj, Caroline Staib, et al.
Journal of Virological Methods|September 26, 2009
The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human useGiulia Di Lullo, Elisa Soprana, Maddalena Panigada, et al.
Journal of Molecular Biology|May 18, 2005
Cell line dependent RNA expression profiles of prion-infected mouse neuronal cellsAlex D Greenwood, Marion Horsch, Anna Stengel, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Virological Methods|November 29, 2008
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selectionGiulia Di Lullo, Elisa Soprana, Maddalena Panigada, et al.
Experimental Cell Research|December 22, 2005
Analysis of the influence of subcellular localization of the HIV Rev protein on Rev-dependent gene expression by multi-fluorescence live-cell imagingHorst Wolff, Kamyar Hadian, Manja Ziegler, et al.
Vaccine|November 8, 2003
Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individualsAntonio Cosma, Rashmi Nagaraj, Silja Bühler, et al.
BMC Cell Biology|April 26, 2005
Identification of a novel Rev-interacting cellular proteinSusanne Kramer-Hämmerle, Francesca Ceccherini-Silberstein, Christian Bickel, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virusAntonio Cosma, Silja Bühler, Rashmi Nagaraj, et al.
Journal of Medical Virology|January 21, 2010
Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletesDieter Hoffmann, Bernd Wolfarth, Hubert G Hörterer, et al.
The Journal of General Virology|March 22, 2002
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaquesCharlotta Nilsson, Gerd Sutter, Lilian Walther-Jallow, et al.
AIDS Research and Human Retroviruses|July 3, 2007
Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAARTAntonio Cosma, Rashmi Nagaraj, Caroline Staib, et al.
Journal of Virological Methods|September 26, 2009
The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human useGiulia Di Lullo, Elisa Soprana, Maddalena Panigada, et al.
Journal of Molecular Biology|May 18, 2005
Cell line dependent RNA expression profiles of prion-infected mouse neuronal cellsAlex D Greenwood, Marion Horsch, Anna Stengel, et al.
Pageof 5